Washington (CNN)Rep. Tom Price last year purchased shares in a medical device manufacturer days before introducing legislation that would have directly benefited the company, raising new ethics concerns for President-elect Donald Trump's nominee for Health and Human Services secretary.
Price bought between $1,001 to $15,000 worth of shares last March in Zimmer Biomet, according to House records reviewed by CNN
The new revelation is the latest example of Price trading stock in a health care firm at the same time as pursuing legislation that could impact a company's share price. The issue has become a major liability for the congressman after The Wall Street Journal reported last month that he traded roughly $300,000 in shares over the past four years in health companies while pursuing legislation that could impact them.
The spending, documented in Federal Election Commission filings, could raise questions from senators at Pruitt’s confirmation hearing, scheduled for Wednesday. Trump ran on a promise to “drain the swamp” in Washington, vanquishing a culture of political patronage exacerbated, in part, by an influx of dark money in elections.
Price bought between $1,001 to $15,000 worth of shares last March in Zimmer Biomet, according to House records reviewed by CNN
The new revelation is the latest example of Price trading stock in a health care firm at the same time as pursuing legislation that could impact a company's share price. The issue has become a major liability for the congressman after The Wall Street Journal reported last month that he traded roughly $300,000 in shares over the past four years in health companies while pursuing legislation that could impact them.
The spending, documented in Federal Election Commission filings, could raise questions from senators at Pruitt’s confirmation hearing, scheduled for Wednesday. Trump ran on a promise to “drain the swamp” in Washington, vanquishing a culture of political patronage exacerbated, in part, by an influx of dark money in elections.
Last edited:
